Om Pharmaceuticals Limited, a active public limited company, was established on 08 November 1994 in Mumbai, Maharashtra, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U24230MH1994PLC082689. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹0.92 M.
It upholds a compliant status. Its leadership includes Chetan Doshi Mansukhlal (Director), Vivek Gul Asrani (Director), Vishal Narindernath Mehra (Director). Past directors included Vasant Mahadeo Patil, Chetan Doshi Mansukhlal, Vishal Narindernath Mehra. It holds ₹4.00 M open charges and ₹8.95 Cr settled loans. Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2025. It is based at 202, Vishwa Nanak Apartments Gurunanak Wadi, Chakala, Andheri (East), Mumbai, Maharashtra, 400099.
U24230MH1994PLC082689
082689
08 November 1994
₹2.00 M
₹0.92 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Om Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chetan Doshi Mansukhlal | Director | 27 Dec 2019 | Current |
| Vivek Gul Asrani | Director | 01 Apr 2005 | Current |
| Vishal Narindernath Mehra | Director | 20 Jul 2012 | Current |
| Pravin Gangadhar Sonawane | Director | 09 Sep 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Jul 2012 | Past |
| Pramod Abcsdd | Director Appointed In Casual Vacancy | 30 Sep 2022 | Past |
| Pramod Abcsdd | Director Appointed In Casual Vacancy | 24 Sep 2013 | Past |
| Pramod Abcsdd | Additional Director | 15 Sep 2024 | Past |
| Pramod Abcsdd | Director | 13 Dec 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Om Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.44% increase. The company also saw a substantial fall in profitability, with a 19.31% decrease in profit. The company's net worth Soared by an impressive increase of 13.91%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Om Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,000,000.00
₹89,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Sep 2024 | Others | ₹4.00 M | Open |
| 10 Oct 2013 | Bank Of Maharashtra | ₹8.50 M | Satisfied |
| 03 Nov 2011 | Bank Of Maharashtra | ₹1.10 Cr | Satisfied |
| 08 Jul 2010 | Bank Of Maharashtra | ₹1.35 Cr | Satisfied |
| 03 Apr 2007 | Others | ₹3.20 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Om Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Om Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Om Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Om Pharmaceuticals Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was documented.
Progress on Om Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Progress on Pravin Gangadhar Sonawane was appointed as a Director was appointed as a Director on 09 Sep 2024 & has been associated with this company since 1 year 2 months . was documented.
The activity A charge with Others amounted to Rs. 4.00 M with Charge ID 100975176 was registered on 06 Sep 2024. was completed.
A charge registered on 03 Apr 2007 via Charge ID 10050777 with Others was fully satisfied on 24 Mar 2024. was recorded as a recent event.
Progress on A charge registered on 10 Oct 2013 via Charge ID 10456602 with Bank Of Maharashtra was fully satisfied on 11 Aug 2020. was documented.
The CIN of Om Pharmaceuticals Limited is U24230MH1994PLC082689.
Om Pharmaceuticals Limited is headquartered at 202, Vishwa Nanak Apartments Gurunanak Wadi, Chakala, Andheri (East), Mumbai, Maharashtra, 400099.
Om Pharmaceuticals Limited was incorporated on 08 November 1994.
The current directors of Om Pharmaceuticals Limited are
The primary industry of Om Pharmaceuticals Limited is Manufacturing.
Om Pharmaceuticals Limited is unlisted.
The authorized capital of Om Pharmaceuticals Limited is ₹2.00 M, and the paid-up capital is ₹0.92 M.
The compliance status of Om Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX